Synlogic reports fourth quarter and full year 2020 financial results and provides business update

Cambridge, mass., march 25, 2021 /prnewswire/ -- synlogic, inc. (nasdaq: sybx), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today reported financial results for the fourth quarter and full year ended december 31, 2020, and provided an update on programs and progress.
SYBX Ratings Summary
SYBX Quant Ranking